高级检索
当前位置: 首页 > 详情页

Mobile Photoplethysmographic Technology to Detect Atrial Fibrillation.

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Chinese People’s Liberation Army General Hospital, Beijing, China [2]Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, China [3]The First Affiliated Hospital of Haerbing Medical University, Haerbing, China [4]The First Affiliated Hospital of Dalian Medical University, Dalian, China [5]Yunnan Cardiovascular Hospital, Kunmin, China [6]Beijing Friendship Hospital, Capital Medical University, Beijing, China [7]Zhengzhou Central Hospital Affiliated to Zhengzhou University, Zhengzhou, China [8]The First Hospital of Jilin University, Changchun, Jilin, China [9]General Hospital of Shenyang Military, Shenyang, China [10]The Second Hospital of Hebei Medical University, Shijiazhuang, China [11]Shanxi Da Hospital, Taiyuan, China [12]Liverpool Centre for Cardiovascular Sciences, University of Liverpool, Liverpool, United Kingdom [13]Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark.
出处:
ISSN:

摘要:
Low detection and nonadherence are major problems in current management approaches for patients with suspected atrial fibrillation (AF). Mobile health devices may enable earlier AF detection and improved AF management. This study sought to investigate the effectiveness of AF screening in a large population-based cohort using smart device-based photoplethysmography (PPG) technology, combined with a clinical care AF management pathway using a mobile health approach. AF screening was performed with smart devices using PPG technology, which were made available for the population ≥18 years of age across China. Monitoring for at least 14 days with a wristband (Honor Band 4) or wristwatch (Huawei Watch GT, Honor Watch, Huawei Technologies Co., Ltd., Shenzhen, China) was allowed. The patients with "possible AF" episodes using the PPG algorithm were further confirmed by health providers among the MAFA (mobile AF app) Telecare center and network hospitals, with clinical evaluation, electrocardiogram, or 24-h Holter monitoring. There were 246,541 individuals who downloaded the PPG screening app, and 187,912 individuals used smart devices to monitor their pulse rhythm between October 26, 2018, and May 20, 2019. Among those with PPG monitoring (mean age 35 years, 86.7% male), 424 (of 187,912, 0.23%) (mean age 54 years, 87.0% male) received a "suspected AF" notification. Of those effectively followed up, 227 individuals (of 262, 87.0%) were confirmed as having AF, with the positive predictive value of PPG signals being 91.6% (95% confidential interval [CI]: 91.5% to 91.8%). Both suspected AF and identified AF markedly increased with age (p for trend <0.001), and individuals in Northeast China had the highest proportion of detected AF of 0.28% (95% CI: 0.20% to 0.39%). Of the individuals with identified AF, 216 (of 227, 95.1%) subsequently entered a program of integrated AF management using a mobile AF application; approximately 80% of high-risk patients were successfully anticoagulated. Based on the present study, continuous home monitoring with smart device-based PPG technology could be a feasible approach for AF screening. This would help efforts at screening and detection of AF, as well as early interventions to reduce stroke and other AF-related complications. (Mobile Health [mHealth] Technology for Improved Screening, Patient Involvement and Optimizing Integrated Care in Atrial Fibrillation [MAFA II]; ChiCTR-OOC-17014138). Copyright © 2019 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

语种:
高被引:
热点:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统
最新[2023]版:
大类 | 1 区 医学
小类 | 1 区 心脏和心血管系统
JCR分区:
出版当年[2018]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS
最新[2023]版:
Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

影响因子: 最新[2023版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Chinese People’s Liberation Army General Hospital, Beijing, China
通讯作者:
通讯机构: [1]Chinese People’s Liberation Army General Hospital, Beijing, China [12]Liverpool Centre for Cardiovascular Sciences, University of Liverpool, Liverpool, United Kingdom [13]Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark. [*1]Chinese PLA General Hospital, Department of Cardiology, No. 28, Fuxin Road, Beijing, 100853 China [*2]Liverpool Centre for Cardiovascular Science, William Henry Duncan Building, West Derby Street, Liverpool, Merseyside L7 8TX, United Kingdom
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:82490 今日访问量:0 总访问量:681 更新日期:2025-01-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 云南省第一人民医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西山区金碧路157号